1C5B | L:109-211; H:1-113; L:1-108; H:114-227 | DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM |
1C5C | L:109-211; H:1-113; L:1-108; H:114-227 | DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX |
1D5B | A:109-211; L:109-211; B:1-113; H:1-113; A:1-108; L:1-108; B:114-213; H:114-213 | UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY |
1D5I | L:109-211; H:1-113; L:1-108; H:114-214 | UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY |
1D6V | L:109-211; H:1-113; L:1-108; H:114-211 | CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION |
1I7Z | A:109-211; B:1-113; D:1-113; A:1-108; C:1-108; B:114-225; D:114-225; C:109-211 | ANTIBODY GNC92H2 BOUND TO LIGAND |
1IT9 | L:113-214; H:1-121; L:1-112; H:122-219 | CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A |
1N7M | H:109-213; H:1-108; L:1-114; L:115-214 | GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN |
1NGW | A:109-213; L:109-213; A:1-108; L:1-108; B:1-114; H:1-114; B:115-214; H:115-214 | CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN |
1NGX | A:109-213; L:109-213; A:1-108; L:1-108; B:1-114; H:1-114; B:115-214; H:115-214 | CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND |
1NGY | A:109-213; A:1-108; B:1-114; B:115-214 | CHIMERIC MATURE FAB 7G12-APO |
1NGZ | A:109-213; A:1-108; B:1-114; B:115-214 | CHIMERIC GERMLINE FAB 7G12-APO |
1Y0L | A:109-214; C:109-214; A:1-108; E:109-214; C:1-108; E:1-108; L:1-108; L:109-214; B:1-113; D:1-113; F:1-113; H:1-113; B:114-233; D:114-233; F:114-233; H:114-233 | CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN |
1Y18 | A:109-214; A:1-108; C:1-108; E:1-108; L:1-108; B:1-113; D:1-113; F:1-113; H:1-113; C:109-214; E:109-214; L:109-214; B:114-233; D:114-233; F:114-233; H:114-233 | FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN |
1YY8 | A:109-213; B:1-118; D:1-118; C:109-213; A:1-108; C:1-108; B:122-219; D:122-219 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225 |
2HH0 | L:153-271; H:152-271; H:1-149; L:2-149 | STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE. |
2O5X | L:108-211; H:114-227; L:1-107; H:1-113 | CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS-ALDERASE FAB WITH NM STEROID-BINDING AFFINITY |
2O5Y | L:108-211; H:114-227; L:1-107; H:1-113 | CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX |
2O5Z | L:108-211; H:114-227; L:1-107; H:1-113 | CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA-ANDROSTANE-3,17-DIONE COMPLEX |
3CFK | A:109-213; H:114-228; I:114-228; K:114-228; N:114-228; P:114-228; A:1-108; C:1-108; E:1-108; G:1-108; J:1-108; L:1-108; M:1-108; O:1-108; B:1-113; C:109-213; D:1-113; F:1-113; H:1-113; I:1-113; K:1-113; N:1-113; P:1-113; E:109-213; G:109-213; J:109-213; L:109-213; M:109-213; O:109-213; B:114-228; D:114-228; F:114-228 | CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM |